Inglis Tiffany Eul Davis 4
4 · SERA PROGNOSTICS, INC. · Filed Oct 15, 2025
Insider Transaction Report
Form 4
Inglis Tiffany Eul Davis
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2025-10-15+107,000→ 107,000 totalExercise: $3.13Exp: 2035-10-15→ Class A Common Stock (107,000 underlying) - Award
Class A Common Stock
2025-10-15+75,000→ 75,000 total
Footnotes (2)
- [F1]Each share is represented by a restricted stock unit ("RSU"). These RSUs vest over four years as follows: 25% of the original grant amount vests on the first anniversary of the vesting commencement date, which is October 10, 2025, and 1/12 of the remaining amount vests in quarterly installments for three years thereafter, subject to the Reporting Person continuing to provide services to the issuer.
- [F2]These stock options vest over four years as follows: 25% of the original grant amount vests on the first anniversary of the vesting commencement date, which is October 10, 2025, and 1/36 of the remaining amount vests in monthly installments for three years thereafter, subject to the Reporting Person continuing to provide services to the issuer.